SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : bluebird bio Inc. -- Ignore unavailable to you. Want to Upgrade?

To: tuck who wrote (69)5/22/2014 11:23:56 AM
From: tuck  Respond to of 163
 
Presenting at the same time is Xeleron, also in beta thalassemia. Their abstract isn't available, maybe a ate breaker?

Cheers, Tuck



To: tuck who wrote (69)5/22/2014 4:23:05 PM
From: idos  Read Replies (1) | Respond to of 163
 
When is transfusion independence established? Is six months too early for such a signal?

It took one year for patient 1003 to became transfusion independent and with the improved vector time to transgene expression could be shorter, but if patients were more sever they might not reach transfusion independence but perhaps transfusion frequency reduction.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News